CClinicalTrials.gg
RecruitingNCT06049914Updated Sep 22, 2023

Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Older Adults in Primary Care

An interventional study of Experimental group in Sarcopenia, sponsored by Kyunghee University Medical Center. Recruiting at 3 sites in Korea, Republic of. Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2023-09-22.

Sponsored by Kyunghee University Medical Center · Not applicable, Interventional, and Screening

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Aug 2023; still recruiting 3 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

The purpose of this study is to assess the impact of a combined exercise-nutrition intervention in primary clinics on sarcopenia indices, physical function, and quality of life in community-dwelling older adults with possible sarcopenia.

Read the detailed description

This study will investigate the effects of a 12-week combined exercise-nutrition intervention by comparing it with a control group receiving standard care (usual care) by assessing the sarcopenia indicators, functional recovery, and individual satisfaction. This is an interventional clinical study designed to recruit subjects, analyze data, identify problems, find improvement areas, and explore potential solutions.

02

Conditions studied

  • Sarcopenia

Browse trials for

Keywords

  • Sarcopenia
  • Elderly
  • Outpatient
  • Exercise
  • Intervention
03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's planned enrollment of 94 is above the median of 60 across 775 interventional studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Kyunghee University Medical Center is the lead sponsor of 62 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 65 to 85 years of age
  • Men and women with possible sarcopenia

    • If included in the possible sarcopenia criteria in the 2019 Asian Working Group for Sarcopenia(AWGS) criteria A Simple Questionnaire to Rapidly Diagnose Sarcopenia(The Korean SARC-F questionnaire) score is 4 or higher; or Calf circumference (Men's: \<34 cm, Women's: \<33 cm) + Decreased muscle strength (male: \<28kg, female: \<18kg) or Decreased physical function (if it takes more than 12 seconds from the 5-chair stand test)
    • [(1) and {(2) or (3)}]

Exclusion criteria

Exclusion Criteria:

  • Renal failure: Serum creatine exceeding 2.0 mg/dl
  • Uncontrolled hypertension: systolic/diastolic blood pressure greater than 150/90 millimeter of mercury(mmHg)
  • Uncontrolled diabetes: glycated hemoglobin (HbA1C) over 7.5%
  • Subject who are receiving treatment (steroids, anticancer drugs, etc.) that can affect muscle mass
  • Subjects with myocardial infarction or angina pectoris, stroke disease
  • Malignant tumor: Subject who has a history of cancer within 5 years or is currently receiving treatment
  • Subjects who have liver cirrhosis and uncontrolled hepatitis (Aspartate aminotransferase or Alanine aminotransferase is more than three times the upper limit of the reference range)
  • Subjects who have chronic diseases such as musculoskeletal disorders that are impossible to exercise
  • Subjects who are allergic to soybeans, coix, and brown rice
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
94 participants (estimated)

Study arms

  • Experimental
    Experimental group

    1. Exercise interventions * Visiting the primary clinic twice a week and exercising at home once a week for a total of 6 weeks during the introductory and expanding period, and then visiting the primary clinic once a week and exercising at home twice a week for 6 weeks during the maintenance period * For exercise intervention, the researcher visits the primary clinic and conducts it face-to-face * Flexibility and strength Exercises: Up to 4 group exercises under the guidance of researchers, up to 40 minutes scheduled 2. Nutritional interventions * Evaluate nutritional status through Mini Nutritional Assessment(MNA) survey at the time of Visit 1 * Supplementary protein products are provided only for the malnourished group and at risk group with a MNA score of 23.5 or lower * Supplementary protein products: 'Mediwell', healthy five-grain flavor, liquid 150 ml, 150 kcal, 20g carbohydrates, 2g sugars, 8g protein, 5g fat

    Behavioral: Experimental group

  • No intervention
    Control group

    * Control group: Providing only video and educational materials without intervention (12 weeks) * Videos and educational materials are provided to both the experimental group and the control group for home exercise. * Subjects write flexibility exercises, strength exercises, aerobic exercises, and meal diaries at home.

Interventions

  • BehavioralExperimental group

    1. Exercise interventions * Measuring blood pressure and weight: before starting exercise * Flexibility exercises: 5-10 minutes of stretching * Strength exercises: Consists of 4 upper body exercises (Biceps Curl, Dips, Front raise, Chest press) and 5 lower body exercises (Leg lateral rotation, Leg extension, Hip abduction, Squat, Heel raise). The intensity of the band starts according to the subject's muscle strength. * Aerobic exercise: 5 times a week, home-based, 30 minutes or more each time 2. Nutritional interventions * Well nourished: Overall diet check and correction * at risk: Correction of diet and intake of up to 2 packs of supplemental protein products per day * Malnourished: Correction of diet and intake of up to 3 packs of supplemental protein products per day * Nutrition counseling is provided at the beginning of the intervention and high-protein diet composition education is provided * Confirm compliance and provide feedback once every 2 weeks

06

What researchers measure

Primary outcomes

  1. 5-time chair stand test

    a test of lower limb function that measures the fastest time taken to stand five times from a chair with arms folded.

    Time frame: Screening, 0st week of intervention, 6th week of intervention, 12th week of intervention

Secondary outcomes

  1. Grip strength

    Measure maximum grip strength with a grip dynamometer

    Time frame: Screening, 0st week of intervention, 6th week of intervention, 12th week of intervention

  2. Falls

    Falls Survey in Last 3 Months

    Time frame: 0st week of intervention, 12th week of intervention, 24th week of intervention

  3. EuroQol Visual Analogue Scale(EQ-VAS)

    a vertical visual analogue scale that takes values between 100 (best imaginable health) and 0 (worst imaginable health), on which patients provide a global assessment of their health.

    Time frame: 0st week of intervention, 12th week of intervention

  4. Korean version of Instrumental Activities of Daily Living (K-IADL)

    Assess the skills and abilities needed to perform specific daily tasks related to an independent lifestyle in Korean version.

    Time frame: 0st week of intervention, 6th week of intervention, 12th week of intervention, 24th week of intervention

  5. Korean version of Physical Activity Scale for the Elderly(K-PASE)

    Measures the level of self-reported physical activity in individuals aged 65 years or older and is comprised of items regarding occupational, household, and leisure activities during the previous 7-day period.

    Time frame: 0st week of intervention, 12th week of intervention

  6. Mini Nutritional Assessment(MNA)

    Mini Nutritional Assessment is a validated nutrition screening and assessment tool that can identify geriatric patients age 65 and above who are malnourished or at risk of malnutrition.

    Time frame: 0st week of intervention, 12th week of intervention

  7. Korean version of Mini-mental State Examination(K-MMSE)

    a set of questions that commonly used to check for cognitive impairment (problems with thinking, communication, understanding and memory).

    Time frame: 0st week of intervention, 12th week of intervention

  8. Korean version of Short Form of Geriatric Depression Scale(SGDS-K)

    Scores of 0-4 are considered normal, depending on age, education, and complaints; 5-8 indicate mild depression; 9-11 indicate moderate depression; and 12-15 indicate severe depression.

    Time frame: 0st week of intervention, 12th week of intervention, 24th week of intervention

  9. The 12-item Health Survey(SF-12)

    Self-reported outcome measure assessing the impact of health on an individual's everyday life. It is used as a quality of life measure.

    Time frame: 0st week of intervention, 12th week of intervention

07

Study locations

3 of 3 sites recruiting
  • Dongdong Family Medicine Clinic
    Dobong, Seoul 01384, Korea, Republic of
    Recruiting
  • Dongbu-hanil Surgery Clinic
    Dobong, Seoul, Korea, Republic of
    Recruiting
  • Seoulbom United Clinic
    Dobong, Seoul, Korea, Republic of
    Recruiting
08

References and documents

Publications

  • Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, Bauer JM, Pahor M, Clark BC, Cesari M, Ruiz J, Sieber CC, Aubertin-Leheudre M, Waters DL, Visvanathan R, Landi F, Villareal DT, Fielding R, Won CW, Theou O, Martin FC, Dong B, Woo J, Flicker L, Ferrucci L, Merchant RA, Cao L, Cederholm T, Ribeiro SML, Rodriguez-Manas L, Anker SD, Lundy J, Gutierrez Robledo LM, Bautmans I, Aprahamian I, Schols JMGA, Izquierdo M, Vellas B. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018;22(10):1148-1161. doi: 10.1007/s12603-018-1139-9. PubMed 30498820 ↗
  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. Erratum In: Age Ageing. 2019 Jul 1;48(4):601. doi: 10.1093/ageing/afz046. PubMed 30312372 ↗
  • Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4. PubMed 32033882 ↗
  • Jang HC. How to Diagnose Sarcopenia in Korean Older Adults? Ann Geriatr Med Res. 2018 Jun;22(2):73-79. doi: 10.4235/agmr.2018.22.2.73. Epub 2018 Jun 30. PubMed 32743250 ↗
  • Malafarina V, Uriz-Otano F, Malafarina C, Martinez JA, Zulet MA. Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial. Maturitas. 2017 Jul;101:42-50. doi: 10.1016/j.maturitas.2017.04.010. Epub 2017 Apr 22. PubMed 28539168 ↗
  • Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, Gallagher ER, Jackson VA, Kambadakone A, Hong TS, Temel JS, Fintelmann FJ. Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer. Oncologist. 2018 Jan;23(1):97-104. doi: 10.1634/theoncologist.2017-0255. Epub 2017 Sep 21. PubMed 28935775 ↗
  • Zhu LY, Chan R, Kwok T, Cheng KC, Ha A, Woo J. Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: a randomized controlled trial. Age Ageing. 2019 Mar 1;48(2):220-228. doi: 10.1093/ageing/afy179. PubMed 30462162 ↗
  • Yamada M, Kimura Y, Ishiyama D, Nishio N, Otobe Y, Tanaka T, Ohji S, Koyama S, Sato A, Suzuki M, Ogawa H, Ichikawa T, Ito D, Arai H. Synergistic effect of bodyweight resistance exercise and protein supplementation on skeletal muscle in sarcopenic or dynapenic older adults. Geriatr Gerontol Int. 2019 May;19(5):429-437. doi: 10.1111/ggi.13643. Epub 2019 Mar 13. PubMed 30864254 ↗
  • Chen HT, Wu HJ, Chen YJ, Ho SY, Chung YC. Effects of 8-week kettlebell training on body composition, muscle strength, pulmonary function, and chronic low-grade inflammation in elderly women with sarcopenia. Exp Gerontol. 2018 Oct 2;112:112-118. doi: 10.1016/j.exger.2018.09.015. Epub 2018 Sep 20. PubMed 30243898 ↗
  • Tsekoura M, Billis E, Tsepis E, Dimitriadis Z, Matzaroglou C, Tyllianakis M, Panagiotopoulos E, Gliatis J. The Effects of Group and Home-Based Exercise Programs in Elderly with Sarcopenia: A Randomized Controlled Trial. J Clin Med. 2018 Nov 26;7(12):480. doi: 10.3390/jcm7120480. PubMed 30486262 ↗
  • Lauque S, Arnaud-Battandier F, Mansourian R, Guigoz Y, Paintin M, Nourhashemi F, Vellas B. Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial. Age Ageing. 2000 Jan;29(1):51-6. doi: 10.1093/ageing/29.1.51. PubMed 10690696 ↗
  • Laddu D, Kim H, Phillips SA, Ma J. INERTIA: A pilot study of the impact of progressive resistance training on blood pressure control in older adults with sarcopenia. Contemp Clin Trials. 2021 Sep;108:106516. doi: 10.1016/j.cct.2021.106516. Epub 2021 Jul 24. PubMed 34311098 ↗
  • Thompson PD, Arena R, Riebe D, Pescatello LS; American College of Sports Medicine. ACSM's new preparticipation health screening recommendations from ACSM's guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep. 2013 Jul-Aug;12(4):215-7. doi: 10.1249/JSR.0b013e31829a68cf. No abstract available. PubMed 23851406 ↗

Individual participant data

Plan to share: Yes — Research information will be provided to third parties (data processing organizations, academic societies, etc.) and used for secondary research. Individual participant data will be stored and used for 5 years after completion of the primary study. When used for secondary research, it will be used after deliberation by the institutional committee, and all information provided will be used only to create statistics for research purposes. The purpose and expected effect of third-party provision of research information and use of secondary research is to contribute to the promotion of national health. Personal information to be collected: Personal identification information (date of birth, name, gender, etc.), personal information (medical records necessary to determine the purpose of this study)

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06049914
Lead sponsor
Kyunghee University Medical Center
Responsible party
Chang Won Won (Principal Investigator, Kyunghee University Medical Center) — Principal investigator
First posted
Sep 22, 2023
Start date
Aug 8, 2023
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Sep 22, 2023

Study contacts

Minjin Kim
Contact
rhdeo64@naver.com
rhdeo64@naver.com ext. +821030741008
Chang Won Won, MD
principal investigator · Kyunghee University Medical Center
Ja Euk Baek
study director · Dongdong Family Medicine Clinic
Seong Euk Kim
study director · Dongbu-hanil Surgery Clinic
Chung Hyeong Lee
study director · Seoulbom United Clinic
Mi Ji Kim
study director · Kyunghee University
Seon Yeong Kim
study director · Kyunghee University Medical Center
Jeong Ha Kim
study director · Chung-Ang University
Jeong Ha Park
study director · Kyunghee University Medical Center
Ga Yang Shim
study director · Kyunghee University Medical Center
Hye Suk Lee
study chair · Kyunghee University Medical Center
Dae Hyun Lee
study chair · Kyunghee University
Hee Eun Jung
study chair · Kyunghee University
Jae Young Jang
study chair · Kyunghee University
Na Hyun Lim
study chair · Kyunghee University
Hyun jin Cho
study chair · Kyunghee University
Min JIn Kim
study chair · Kyunghee University
Woohyuk Ji
study chair · Kyunghee University Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion